| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.921 | 0.004 | 0.921 | Analgesic | 0.785 0.007 CID_76973589 0.85 0.005 CID_154699758 | ||
| 0.81 | 0.003 | 0.81 | NMDA receptor antagonist | 0.106 0.044 CID_76973589 0.76 0.003 CID_154699758 | ||
| 0.783 | 0.004 | 0.783 | 5 Hydroxytryptamine release stimulant | 0.676 0.009 CID_76973589 0.312 0.066 CID_154699758 | ||
| 0.769 | 0.001 | 0.769 | NMDA receptor phencyclidine site antagonist | 0.02 0.007 CID_76973589 0.071 0.003 CID_154699758 | ||
| 0.76 | 0.002 | 0.76 | NMDA 2C receptor antagonist | 0.065 0.038 CID_76973589 0.68 0.002 CID_154699758 | ||
| 0.745 | 0.003 | 0.745 | Opioid antagonist | 0.468 0.004 CID_76973589 0.578 0.004 CID_154699758 | ||
| 0.741 | 0.003 | 0.741 | Analgesic, opioid | 0.477 0.004 CID_76973589 0.626 0.003 CID_154699758 | ||
| 0.733 | 0.002 | 0.733 | Opioid agonist | 0.416 0.004 CID_76973589 0.607 0.003 CID_154699758 | ||
| 0.706 | 0.003 | 0.706 | Sigma receptor agonist | 0.586 0.005 CID_76973589 0.638 0.004 CID_154699758 | ||
| 0.701 | 0.003 | 0.701 | Opioid mu receptor antagonist | 0.435 0.004 CID_76973589 0.549 0.004 CID_154699758 | ||
| 0.688 | 0.002 | 0.688 | NMDA receptor subunit 3A antagonist | 0.061 0.016 CID_76973589 0.085 0.01 CID_154699758 | ||
| 0.668 | 0.002 | 0.668 | Opioid mu receptor agonist | 0.356 0.004 CID_76973589 0.521 0.003 CID_154699758 | ||
| 0.668 | 0.003 | 0.737 | NMDA 2 receptor antagonist | 0.737 0.003 CID_154699758 | CID_154699758 | |
| 0.667 | 0.003 | 0.667 | Opioid delta receptor antagonist | 0.269 0.005 CID_76973589 0.312 0.005 CID_154699758 | ||
| 0.641 | 0.002 | 0.641 | Opioid kappa receptor antagonist | 0.429 0.004 CID_76973589 0.482 0.003 CID_154699758 | ||
| 0.568 | 0.003 | 0.568 | Opioid delta receptor agonist | 0.146 0.005 CID_76973589 0.166 0.004 CID_154699758 | ||
| 0.58 | 0.015 | 0.682 | Spasmolytic | 0.682 0.007 CID_76973589 0.482 0.026 CID_154699758 | CID_76973589 | |
| 0.558 | 0.004 | 0.558 | Acetylcholine nicotinic antagonist | 0.101 0.038 CID_76973589 0.189 0.014 CID_154699758 | ||
| 0.528 | 0.002 | 0.528 | NMDA receptor subunit 3B antagonist | 0.04 0.035 CID_76973589 0.039 0.036 CID_154699758 | ||
| 0.493 | 0.004 | 0.493 | Sigma receptor antagonist | 0.054 0.032 CID_76973589 0.12 0.014 CID_154699758 | ||
| 0.49 | 0.005 | 0.49 | Cholinergic antagonist | 0.153 0.051 CID_76973589 0.22 0.027 CID_154699758 | ||
| 0.489 | 0.005 | 0.489 | Acetylcholine antagonist | 0.136 0.058 CID_76973589 0.222 0.026 CID_154699758 | ||
| 0.47 | 0.004 | 0.47 | Neuronal nicotinic receptor antagonist | 0.061 0.053 CID_76973589 0.165 0.011 CID_154699758 | ||
| 0.458 | 0.002 | 0.458 | Opioid kappa receptor agonist | 0.293 0.003 CID_76973589 0.337 0.003 CID_154699758 | ||
| 0.442 | 0.004 | 0.442 | Alpha 2a adrenoreceptor antagonist | 0.08 0.049 CID_154699758 | ||
| 0.433 | 0.002 | 0.433 | Prolactin inhibitor | 0.095 0.061 CID_76973589 0.195 0.009 CID_154699758 | ||
| 0.429 | 0.005 | 0.429 | Antipruritic | 0.302 0.014 CID_76973589 0.226 0.034 CID_154699758 | ||
| 0.467 | 0.045 | 0.61 | Antiobesity | 0.482 0.041 CID_76973589 0.61 0.019 CID_154699758 | CID_154699758 | |
| 0.427 | 0.019 | 0.436 | Psychostimulant | 0.436 0.017 CID_76973589 | CID_76973589 | |
| 0.457 | 0.052 | 0.752 | Transcription factor NF kappa B inhibitor | 0.752 0.016 CID_76973589 0.244 0.132 CID_154699758 | CID_76973589 | |
| 0.402 | 0.004 | 0.402 | Dopamine D1 antagonist | 0.065 0.045 CID_154699758 | ||
| 0.398 | 0.005 | 0.398 | Dopamine agonist | 0.122 0.02 CID_76973589 0.307 0.005 CID_154699758 | ||
| 0.392 | 0.003 | 0.392 | Toll-Like receptor 4 antagonist | 0.323 0.003 CID_76973589 0.248 0.004 CID_154699758 | ||
| 0.394 | 0.01 | 0.394 | Cholinergic | 0.157 0.071 CID_76973589 0.197 0.048 CID_154699758 | ||
| 0.385 | 0.004 | 0.385 | Toll-Like receptor antagonist | 0.175 0.041 CID_76973589 | ||
| 0.432 | 0.052 | 0.539 | Immunosuppressant | 0.539 0.023 CID_76973589 0.364 0.079 CID_154699758 | CID_76973589 | |
| 0.369 | 0.003 | 0.369 | NMDA 2A receptor antagonist | 0.179 0.005 CID_154699758 | ||
| 0.367 | 0.005 | 0.367 | Alpha 2 adrenoreceptor antagonist | |||
| 0.379 | 0.019 | 0.379 | Anesthetic general | 0.359 0.022 CID_76973589 | ||
| 0.368 | 0.012 | 0.368 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.365 | 0.022 | 0.365 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.343 | 0.006 | 0.343 | Nav1.1 sodium channel blocker | 0.116 0.051 CID_76973589 0.161 0.029 CID_154699758 | ||
| 0.336 | 0.005 | 0.336 | Acetylcholine agonist | 0.084 0.061 CID_154699758 | ||
| 0.341 | 0.009 | 0.341 | Acetylcholine M1 receptor antagonist | 0.118 0.111 CID_76973589 0.173 0.056 CID_154699758 | ||
| 0.421 | 0.099 | 0.421 | Caspase 9 stimulant | 0.397 0.113 CID_76973589 | ||
| 0.332 | 0.013 | 0.332 | Alpha adrenoreceptor antagonist | 0.138 0.041 CID_154699758 | ||
| 0.351 | 0.037 | 0.351 | HERG channel blocker | |||
| 0.34 | 0.039 | 0.34 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.3 | 0.01 | 0.3 | Glutamate receptor antagonist | 0.234 0.018 CID_154699758 | ||
| 0.287 | 0.012 | 0.287 | Dopamine antagonist | |||
| 0.324 | 0.055 | 0.359 | Hypoxia-inducible factor 1 alpha inhibitor | 0.359 0.042 CID_76973589 | CID_76973589 | |
| 0.27 | 0.012 | 0.27 | Dopamine D2 antagonist | |||
| 0.274 | 0.019 | 0.312 | Interleukin 6 antagonist | 0.312 0.013 CID_76973589 | CID_76973589 | |
| 0.259 | 0.005 | 0.259 | Dopamine uptake inhibitor | |||
| 0.314 | 0.063 | 0.314 | Aldehyde oxidase inhibitor | |||
| 0.258 | 0.009 | 0.258 | Nav1.6 sodium channel blocker | |||
| 0.261 | 0.013 | 0.261 | Alpha 2b adrenoreceptor antagonist | |||
| 0.249 | 0.002 | 0.249 | Dopamine D5 agonist | 0.057 0.013 CID_154699758 | ||
| 0.389 | 0.146 | 0.731 | Antiinflammatory | 0.731 0.025 CID_76973589 0.438 0.116 CID_154699758 | CID_76973589 | |
| 0.307 | 0.073 | 0.307 | Sodium/bile acid cotransporter inhibitor | 0.251 0.127 CID_76973589 0.246 0.132 CID_154699758 | ||
| 0.252 | 0.021 | 0.268 | Nav1.2 sodium channel blocker | 0.268 0.019 CID_154699758 | CID_154699758 | |
| 0.242 | 0.016 | 0.242 | Acetylcholine muscarinic antagonist | 0.116 0.072 CID_154699758 | ||
| 0.273 | 0.048 | 0.273 | Anticonvulsant | 0.252 0.056 CID_154699758 | ||
| 0.227 | 0.005 | 0.227 | Dopamine D5 antagonist | 0.058 0.02 CID_154699758 | ||
| 0.276 | 0.055 | 0.276 | Potassium channel blocker | |||
| 0.342 | 0.123 | 0.342 | Calcium channel L-type activator | |||
| 0.221 | 0.003 | 0.221 | Nicotinic receptor beta4 subunit antagonist | 0.104 0.006 CID_76973589 0.149 0.004 CID_154699758 | ||
| 0.304 | 0.088 | 0.304 | Calcium channel activator | |||
| 0.211 | 0.004 | 0.211 | Acetylcholine M3 receptor agonist | 0.167 0.012 CID_76973589 0.186 0.006 CID_154699758 | ||
| 0.208 | 0.005 | 0.208 | Acetylcholine muscarinic agonist | |||
| 0.212 | 0.01 | 0.212 | Antineoplastic alkaloid | 0.105 0.044 CID_76973589 0.076 0.07 CID_154699758 | ||
| 0.265 | 0.066 | 0.31 | Superoxide dismutase inhibitor | 0.31 0.047 CID_154699758 | CID_154699758 | |
| 0.217 | 0.021 | 0.217 | Antiadrenergic | 0.092 0.061 CID_154699758 | ||
| 0.212 | 0.021 | 0.212 | Adrenaline antagonist | 0.089 0.061 CID_154699758 | ||
| 0.204 | 0.017 | 0.204 | Alpha 2c adrenoreceptor antagonist | |||
| 0.244 | 0.07 | 0.401 | DNA synthesis inhibitor | 0.401 0.021 CID_76973589 | CID_76973589 | |
| 0.176 | 0.005 | 0.176 | Acetylcholine M1 receptor agonist | |||
| 0.196 | 0.026 | 0.196 | Adenylate cyclase inhibitor | 0.131 0.059 CID_76973589 | ||
| 0.187 | 0.018 | 0.187 | Alpha 1a adrenoreceptor antagonist | |||
| 0.191 | 0.022 | 0.191 | Alpha 1 adrenoreceptor antagonist | |||
| 0.172 | 0.012 | 0.172 | Alpha adrenoreceptor agonist | |||
| 0.16 | 0.006 | 0.238 | Dopamine D2 agonist | 0.074 0.016 CID_76973589 0.238 0.005 CID_154699758 | CID_154699758 | |
| 0.17 | 0.018 | 0.17 | Estrogen antagonist | |||
| 0.213 | 0.063 | 0.395 | Nitric oxide antagonist | 0.395 0.026 CID_76973589 0.143 0.102 CID_154699758 | CID_76973589 | |
| 0.154 | 0.009 | 0.154 | Adrenaline uptake inhibitor | 0.056 0.049 CID_76973589 0.057 0.048 CID_154699758 | ||
| 0.164 | 0.019 | 0.164 | Alpha 1b adrenoreceptor antagonist | |||
| 0.148 | 0.004 | 0.148 | Nicotinic receptor alpha4 subunit antagonist | 0.053 0.028 CID_76973589 0.092 0.01 CID_154699758 | ||
| 0.2 | 0.056 | 0.2 | Lipocortins synthesis antagonist | 0.183 0.068 CID_76973589 | ||
| 0.171 | 0.035 | 0.171 | Adenylate cyclase stimulant | 0.149 0.064 CID_154699758 | ||
| 0.205 | 0.071 | 0.211 | Neurotrophic factor enhancer | 0.211 0.066 CID_76973589 | CID_76973589 | |
| 0.138 | 0.007 | 0.138 | Oxytocin antagonist | 0.043 0.021 CID_154699758 | ||
| 0.133 | 0.003 | 0.133 | Prolactin release inhibitor | 0.092 0.005 CID_76973589 0.106 0.004 CID_154699758 | ||
| 0.159 | 0.029 | 0.159 | Interleukin 8 antagonist | |||
| 0.167 | 0.038 | 0.167 | Nav1.3 sodium channel blocker | |||
| 0.226 | 0.098 | 0.509 | Antioxidant | 0.509 0.019 CID_76973589 0.263 0.077 CID_154699758 | CID_76973589 | |
| 0.143 | 0.016 | 0.143 | Dopamine D3 antagonist | |||
| 0.143 | 0.017 | 0.143 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.221 | 0.095 | 0.588 | Hypoglycemic | 0.588 0.009 CID_76973589 | CID_76973589 | |
| 0.169 | 0.044 | 0.169 | Acetylcholinesterase inhibitor | |||
| 0.141 | 0.018 | 0.141 | Estrogen receptor beta antagonist | |||
| 0.127 | 0.005 | 0.127 | Nociceptin (N/OFQ) receptor antagonist | 0.038 0.022 CID_154699758 | ||
| 0.135 | 0.017 | 0.135 | Alpha 1d adrenoreceptor antagonist | |||
| 0.227 | 0.109 | 0.227 | Gastrin inhibitor | 0.184 0.174 CID_76973589 | ||
| 0.129 | 0.014 | 0.129 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.168 | 0.057 | 0.313 | Protein kinase stimulant | 0.313 0.015 CID_76973589 | CID_76973589 | |
| 0.114 | 0.003 | 0.114 | Dopamine D1 agonist | 0.081 0.004 CID_76973589 0.112 0.003 CID_154699758 | ||
| 0.163 | 0.061 | 0.292 | NOS3 expression enhancer | 0.292 0.019 CID_76973589 | CID_76973589 | |
| 0.106 | 0.006 | 0.106 | Acetylcholine M2 receptor agonist | 0.058 0.031 CID_76973589 0.075 0.016 CID_154699758 | ||
| 0.213 | 0.116 | 0.213 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.162 | 0.064 | 0.305 | Interferon gamma antagonist | 0.305 0.019 CID_76973589 | CID_76973589 | |
| 0.105 | 0.007 | 0.105 | 5 Hydroxytryptamine 2C agonist | 0.053 0.026 CID_154699758 | ||
| 0.119 | 0.024 | 0.119 | Alpha 2d adrenoreceptor antagonist | 0.088 0.075 CID_154699758 | ||
| 0.099 | 0.007 | 0.099 | Lysine-specific demethylase 1A inhibitor | |||
| 0.096 | 0.004 | 0.096 | Vasopressin 1B antagonist | 0.034 0.014 CID_154699758 | ||
| 0.118 | 0.027 | 0.118 | Acetylcholine nicotinic agonist | |||
| 0.137 | 0.047 | 0.137 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.12 | 0.033 | 0.12 | Androgen antagonist | |||
| 0.099 | 0.012 | 0.099 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.094 | 0.009 | 0.094 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.154 | 0.07 | 0.285 | Insulin secretagoues | 0.285 0.014 CID_76973589 | CID_76973589 | |
| 0.101 | 0.017 | 0.187 | Estrogen agonist | 0.058 0.031 CID_76973589 0.187 0.009 CID_154699758 | CID_154699758 | |
| 0.087 | 0.007 | 0.087 | Vasopressin 2 antagonist | 0.04 0.018 CID_154699758 | ||
| 0.148 | 0.07 | 0.252 | Lipid peroxidase inhibitor | 0.252 0.026 CID_76973589 | CID_76973589 | |
| 0.089 | 0.012 | 0.089 | 5 Hydroxytryptamine 2 agonist | |||
| 0.124 | 0.047 | 0.124 | GABA C receptor agonist | |||
| 0.099 | 0.023 | 0.099 | CC chemokine 5 receptor agonist | 0.087 0.043 CID_154699758 | ||
| 0.225 | 0.149 | 0.393 | Interleukin 2 agonist | 0.393 0.029 CID_76973589 | CID_76973589 | |
| 0.08 | 0.004 | 0.08 | Alpha 1L adrenoreceptor agonist | 0.047 0.021 CID_76973589 0.067 0.006 CID_154699758 | ||
| 0.086 | 0.01 | 0.086 | Vasopressin 1 antagonist | |||
| 0.088 | 0.013 | 0.097 | Estrogen receptor beta agonist | 0.097 0.012 CID_154699758 | CID_154699758 | |
| 0.117 | 0.043 | 0.117 | Creatine kinase inhibitor | |||
| 0.117 | 0.043 | 0.126 | Anabolic | 0.126 0.034 CID_154699758 | CID_154699758 | |
| 0.078 | 0.005 | 0.078 | Sigma 2 receptor antagonist | |||
| 0.091 | 0.018 | 0.091 | Androgen agonist | 0.069 0.032 CID_154699758 | ||
| 0.086 | 0.015 | 0.086 | Antidiuretic hormone antagonist | |||
| 0.223 | 0.151 | 0.223 | Vasodilator, peripheral | 0.207 0.168 CID_76973589 | ||
| 0.089 | 0.019 | 0.089 | Alpha 2 adrenoreceptor agonist | |||
| 0.078 | 0.008 | 0.078 | Vasopressin 1A antagonist | |||
| 0.089 | 0.02 | 0.089 | Alpha 1 adrenoreceptor agonist | |||
| 0.075 | 0.006 | 0.075 | Acetylcholine M4 receptor agonist | |||
| 0.092 | 0.026 | 0.092 | Glycine receptor agonist | 0.081 0.037 CID_76973589 | ||
| 0.181 | 0.121 | 0.318 | Vasodilator | 0.318 0.042 CID_76973589 | CID_76973589 | |
| 0.118 | 0.06 | 0.118 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.062 | 0.004 | 0.062 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.091 | 0.034 | 0.091 | Estrogen receptor alpha antagonist | |||
| 0.082 | 0.026 | 0.082 | 5 Hydroxytryptamine 2A agonist | |||
| 0.079 | 0.026 | 0.079 | Acetylcholine M3 receptor antagonist | |||
| 0.085 | 0.033 | 0.085 | MAP kinase kinase 7 inhibitor | |||
| 0.093 | 0.042 | 0.093 | Adrenaline agonist | |||
| 0.11 | 0.059 | 0.11 | DOPA decarboxylase inhibitor | |||
| 0.09 | 0.041 | 0.09 | Estrogen-related receptor beta agonist | |||
| 0.062 | 0.014 | 0.062 | Neurokinin 1 antagonist | |||
| 0.069 | 0.021 | 0.069 | Glycine transporter inhibitor | |||
| 0.144 | 0.096 | 0.144 | Arachidonic acid antagonist | |||
| 0.058 | 0.013 | 0.058 | Substance P antagonist | |||
| 0.141 | 0.095 | 0.206 | Melanin inhibitor | 0.206 0.038 CID_76973589 | CID_76973589 | |
| 0.058 | 0.013 | 0.058 | Glycine transporter 1 inhibitor | |||
| 0.059 | 0.015 | 0.059 | Estrogen receptor alpha agonist | |||
| 0.087 | 0.044 | 0.087 | Somatostatin 1 agonist | |||
| 0.084 | 0.042 | 0.084 | Acetylcholine M4 receptor antagonist | |||
| 0.059 | 0.019 | 0.059 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.107 | 0.068 | 0.107 | GABA C receptor antagonist | |||
| 0.061 | 0.024 | 0.061 | Neurokinin antagonist | |||
| 0.049 | 0.016 | 0.085 | Arginase inhibitor | 0.085 0.005 CID_76973589 | CID_76973589 | |
| 0.059 | 0.026 | 0.059 | Dopamine transporter inhibitor | |||
| 0.119 | 0.087 | 0.119 | Toll-Like receptor 9 antagonist | |||
| 0.04 | 0.008 | 0.04 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.047 | 0.015 | 0.047 | 5 Hydroxytryptamine 2B agonist | |||
| 0.149 | 0.118 | 0.164 | P-glycoprotein inhibitor | 0.164 0.097 CID_76973589 | CID_76973589 | |
| 0.118 | 0.087 | 0.118 | Bone formation stimulant | 0.106 0.099 CID_76973589 | ||
| 0.103 | 0.072 | 0.103 | 5 Hydroxytryptamine 3A agonist | |||
| 0.107 | 0.077 | 0.107 | Anesthetic local | |||
| 0.047 | 0.018 | 0.047 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.172 | 0.143 | 0.194 | DNA damaging | 0.194 0.12 CID_76973589 | CID_76973589 | |
| 0.103 | 0.076 | 0.103 | 5 Hydroxytryptamine antagonist | |||
| 0.132 | 0.106 | 0.132 | Ca2+-transporting ATPase inhibitor | |||
| 0.063 | 0.037 | 0.063 | Acetylcholine M5 receptor antagonist | |||
| 0.053 | 0.027 | 0.053 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | |||
| 0.078 | 0.052 | 0.109 | Na+ K+ transporting ATPase inhibitor | 0.109 0.023 CID_76973589 0.083 0.048 CID_154699758 | CID_76973589 | |
| 0.083 | 0.059 | 0.083 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.165 | 0.143 | 0.463 | Immunostimulant | 0.463 0.034 CID_76973589 0.22 0.109 CID_154699758 | CID_76973589 | |
| 0.056 | 0.035 | 0.269 | NMDA 2B receptor antagonist | 0.269 0.005 CID_154699758 | CID_154699758 | |
| 0.078 | 0.059 | 0.128 | Glycine receptor antagonist | 0.128 0.014 CID_76973589 0.128 0.014 CID_154699758 | CID_154699758 | |
| 0.162 | 0.143 | 0.385 | Tumour necrosis factor alpha release inhibitor | 0.385 0.029 CID_76973589 | CID_76973589 | |
| 0.061 | 0.044 | 0.061 | Heme oxygenase stimulant | |||
| 0.023 | 0.005 | 0.023 | Nicotinic alpha4 receptor agonist | |||
| 0.058 | 0.043 | 0.058 | Aromatase inhibitor | |||
| 0.031 | 0.016 | 0.031 | Sigma 1 receptor antagonist | |||
| 0.032 | 0.019 | 0.032 | Dipeptidyl peptidase I inhibitor | |||
| 0.076 | 0.062 | 0.076 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.054 | 0.041 | 0.054 | Nicotinic neuronal receptor agonist | |||
| 0.025 | 0.012 | 0.025 | Nociceptin (N/OFQ) receptor agonist | |||
| 0.051 | 0.041 | 0.051 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.032 | 0.024 | 0.032 | Estrogen-related receptor beta antagonist | |||
| 0.096 | 0.093 | 0.111 | Cholesterol synthesis inhibitor | 0.111 0.074 CID_154699758 | CID_154699758 | |
| 0.242 | 0.239 | 0.306 | 5 Hydroxytryptamine release inhibitor | 0.306 0.158 CID_76973589 | CID_76973589 | |
| 0.03 | 0.029 | 0.03 | Progesterone antagonist | |||
| 0.137 | 0.137 | 0.138 | Phospholipase C inhibitor | 0.138 0.134 CID_154699758 | CID_154699758 | |
| 0.053 | 0.054 | 0.067 | Lipocortins synthesis agonist | 0.067 0.024 CID_76973589 | CID_76973589 | |
| 0.113 | 0.114 | 0.461 | Diuretic | 0.26 0.029 CID_76973589 0.461 0.009 CID_154699758 | CID_154699758 | |
| 0.077 | 0.079 | 0.082 | Interleukin 5 antagonist | 0.082 0.068 CID_76973589 | CID_76973589 | |
| 0.045 | 0.052 | 0.053 | Factor III inhibitor | 0.053 0.027 CID_76973589 | CID_76973589 | |
| 0.098 | 0.107 | 0.259 | Cyclooxygenase 3 inhibitor | 0.259 0.008 CID_76973589 | CID_76973589 | |
| 0.07 | 0.082 | 0.085 | Inducible nitric-oxide synthase inhibitor | 0.085 0.054 CID_154699758 | CID_154699758 | |
| 0.044 | 0.059 | 0.092 | Alpha-mannosidase inhibitor | 0.092 0.008 CID_76973589 0.054 0.036 CID_154699758 | CID_76973589 | |
| 0.058 | 0.084 | 0.072 | Phospholipase D inhibitor | 0.072 0.05 CID_154699758 | CID_154699758 | |
| 0.11 | 0.138 | 0.396 | Hemostatic | 0.396 0.008 CID_76973589 0.376 0.009 CID_154699758 | CID_76973589 | |
| 0.22 | 0.249 | 0.475 | Apoptosis agonist | 0.475 0.082 CID_76973589 | CID_76973589 | |
| 0.011 | 0.041 | 0.135 | Estrone sulfatase inhibitor | 0.135 0.004 CID_154699758 | CID_154699758 | |
| 0.087 | 0.117 | 0.119 | Microtubule formation inhibitor | 0.119 0.062 CID_76973589 | CID_76973589 | |
| 0.082 | 0.116 | 0.18 | Alkylator | 0.18 0.033 CID_76973589 | CID_76973589 | |
| 0.195 | 0.235 | 0.603 | Antibacterial | 0.603 0.019 CID_76973589 0.321 0.12 CID_154699758 | CID_76973589 | |
| 0.117 | 0.158 | 0.357 | Hepatoprotectant | 0.357 0.018 CID_76973589 0.147 0.113 CID_154699758 | CID_76973589 | |
| 0.028 | 0.071 | 0.083 | Mannosidase inhibitor | 0.083 0.008 CID_76973589 | CID_76973589 | |
| 0.083 | 0.132 | 0.155 | Alpha-N-acetylglucosaminidase inhibitor | 0.155 0.052 CID_76973589 | CID_76973589 | |
| 0.128 | 0.186 | 0.282 | Interleukin agonist | 0.282 0.058 CID_76973589 | CID_76973589 | |
| 0.041 | 0.1 | 0.055 | Sphingosine kinase inhibitor | 0.055 0.049 CID_154699758 | CID_154699758 | |
| 0.065 | 0.125 | 0.22 | Expectorant | 0.22 0.017 CID_76973589 | CID_76973589 | |
| 0.016 | 0.082 | 0.035 | 1,3-Beta-glucan synthase inhibitor | 0.035 0.007 CID_154699758 | CID_154699758 | |
| 0.166 | 0.234 | 0.23 | Caspase 3 stimulant | 0.23 0.132 CID_76973589 | CID_76973589 | |
| 0.146 | 0.229 | 0.345 | Cholesterol antagonist | 0.345 0.066 CID_76973589 0.199 0.165 CID_154699758 | CID_76973589 | |
| 0.029 | 0.13 | 0.142 | Antineoplastic antibiotic | 0.142 0.033 CID_76973589 | CID_76973589 | |
| 0.189 | 0.291 | 0.688 | Cyclophilin D inhibitor | 0.688 0.015 CID_76973589 0.252 0.211 CID_154699758 | CID_76973589 | |
| 0.072 | 0.178 | 0.115 | Acetylcholine release stimulant | 0.115 0.056 CID_154699758 | CID_154699758 | |
| 0.059 | 0.166 | 0.103 | DNA polymerase I inhibitor | 0.103 0.083 CID_76973589 | CID_76973589 | |
| 0.011 | 0.119 | 0.041 | Sodium/glucose cotransporter inhibitor | 0.041 0.007 CID_76973589 | CID_76973589 | |
| 0.06 | 0.169 | 0.245 | Amylase inhibitor | 0.245 0.029 CID_76973589 | CID_76973589 | |
| 0.156 | 0.272 | 0.269 | Histamine release inhibitor | 0.269 0.142 CID_76973589 | CID_76973589 | |
| 0.115 | 0.231 | 0.201 | Cyclic AMP phosphodiesterase inhibitor | 0.201 0.092 CID_76973589 | CID_76973589 | |
| 0.103 | 0.22 | 0.388 | Free radical scavenger | 0.388 0.031 CID_76973589 | CID_76973589 | |
| 0.027 | 0.157 | 0.106 | HIV-1 integrase (3'-Processing) inhibitor | 0.106 0.024 CID_154699758 | CID_154699758 | |
| 0.007 | 0.152 | 0.035 | Sodium/glucose cotransporter 2 inhibitor | 0.035 0.01 CID_76973589 | CID_76973589 | |
| 0.067 | 0.215 | 0.539 | Angiogenesis stimulant | 0.539 0.01 CID_76973589 0.338 0.036 CID_154699758 | CID_76973589 | |
| 0.06 | 0.212 | 0.092 | Phosphodiesterase 6D inhibitor | 0.092 0.07 CID_76973589 | CID_76973589 | |
| 0.01 | 0.166 | 0.031 | Protein 30S ribosomal subunit inhibitor | 0.031 0.012 CID_76973589 | CID_76973589 | |
| 0.072 | 0.229 | 0.207 | Cell wall synthesis inhibitor | 0.207 0.027 CID_76973589 0.173 0.045 CID_154699758 | CID_76973589 | |
| 0.102 | 0.262 | 0.135 | CC chemokine 6 receptor antagonist | 0.135 0.052 CID_76973589 | CID_76973589 | |
| 0.051 | 0.213 | 0.167 | AMP-activated protein kinase stimulant | 0.167 0.019 CID_76973589 | CID_76973589 | |
| 0.044 | 0.21 | 0.1 | UDP-glucose 4-epimerase inhibitor | 0.1 0.061 CID_76973589 | CID_76973589 | |
| 0.137 | 0.305 | 0.347 | Apoptosis antagonist | 0.347 0.057 CID_76973589 | CID_76973589 | |
| 0.124 | 0.295 | 0.534 | Antithrombotic | 0.534 0.025 CID_76973589 0.275 0.107 CID_154699758 | CID_76973589 | |
| 0.004 | 0.18 | 0.277 | Cholecystokinin B antagonist | 0.277 0.004 CID_154699758 | CID_154699758 | |
| 0.033 | 0.219 | 0.058 | Adenine nucleotide translocase inhibitor | 0.053 0.047 CID_76973589 0.058 0.032 CID_154699758 | CID_154699758 | |
| 0.039 | 0.226 | 0.137 | Topoisomerase II inhibitor | 0.137 0.056 CID_76973589 | CID_76973589 | |
| 0.048 | 0.247 | 0.114 | Transcription factor NF kappa B stimulant | 0.114 0.028 CID_76973589 | CID_76973589 | |
| 0.023 | 0.221 | 0.065 | Glucose-6-phosphate translocase inhibitor | 0.065 0.019 CID_76973589 | CID_76973589 | |
| 0.03 | 0.233 | 0.132 | Topoisomerase I inhibitor | 0.132 0.049 CID_76973589 | CID_76973589 | |
| 0.016 | 0.23 | 0.083 | Protein 50S ribosomal subunit inhibitor | 0.083 0.018 CID_76973589 | CID_76973589 | |
| 0.014 | 0.234 | 0.028 | Toll-Like receptor 4 agonist | 0.028 0.014 CID_76973589 0.028 0.014 CID_154699758 | CID_154699758 | |
| 0.043 | 0.263 | 0.241 | Thrombolytic | 0.241 0.036 CID_76973589 0.137 0.093 CID_154699758 | CID_76973589 | |
| 0.013 | 0.24 | 0.074 | HIV-1 integrase (Strand Transfer) inhibitor | 0.074 0.034 CID_154699758 | CID_154699758 | |
| 0.016 | 0.247 | 0.062 | Antibiotic Aminoglycoside-like | 0.062 0.008 CID_76973589 | CID_76973589 | |
| 0.109 | 0.341 | 0.278 | Vasodilator, coronary | 0.278 0.107 CID_76973589 | CID_76973589 | |
| 0.005 | 0.251 | 0.283 | Cholecystokinin antagonist | 0.283 0.004 CID_154699758 | CID_154699758 | |
| 0.038 | 0.29 | 0.094 | Triose-phosphate isomerase inhibitor | 0.094 0.054 CID_154699758 | CID_154699758 | |
| 0.004 | 0.263 | 0.314 | Cholecystokinin A antagonist | 0.314 0.004 CID_154699758 | CID_154699758 | |
| 0.036 | 0.3 | 0.1 | Beta glucuronidase inhibitor | 0.1 0.069 CID_76973589 | CID_76973589 | |
| 0.013 | 0.28 | 0.61 | Cholecystokinin B agonist | 0.61 0.002 CID_154699758 | CID_154699758 | |
| 0.008 | 0.284 | 0.045 | NMDA 2D receptor antagonist | 0.045 0.008 CID_154699758 | CID_154699758 | |
| 0.061 | 0.36 | 0.164 | Non-steroidal antiinflammatory agent | 0.164 0.1 CID_76973589 | CID_76973589 | |
| 0.103 | 0.403 | 0.332 | Peptidyltransferase inhibitor | 0.332 0.015 CID_76973589 | CID_76973589 | |
| 0.016 | 0.333 | 0.082 | CDC25A inhibitor | 0.082 0.041 CID_154699758 | CID_154699758 | |
| 0.033 | 0.354 | 0.082 | Thioredoxin inhibitor | 0.082 0.078 CID_76973589 | CID_76973589 | |
| 0.031 | 0.355 | 0.189 | Protein-tyrosine phosphatase inhibitor | 0.189 0.051 CID_154699758 | CID_154699758 | |
| 0.009 | 0.373 | 0.289 | Selectin antagonist | 0.289 0.006 CID_76973589 0.09 0.032 CID_154699758 | CID_76973589 | |
| 0.054 | 0.445 | 0.142 | ATPase inhibitor | 0.142 0.116 CID_76973589 | CID_76973589 | |
| 0.021 | 0.414 | 0.099 | ATPase (Vacuolar H+) inhibitor | 0.099 0.041 CID_76973589 | CID_76973589 | |
| 0.039 | 0.452 | 0.292 | Platelet adhesion inhibitor | 0.292 0.037 CID_76973589 0.198 0.072 CID_154699758 | CID_76973589 | |
| 0.015 | 0.444 | 0.059 | Heparanase inhibitor | 0.059 0.025 CID_76973589 | CID_76973589 | |
| 0.065 | 0.5 | 0.317 | Immunomodulator | 0.317 0.073 CID_76973589 | CID_76973589 | |
| 0.044 | 0.503 | 0.108 | DNA repair enzyme inhibitor | 0.108 0.103 CID_76973589 | CID_76973589 | |
| 0.03 | 0.491 | 0.196 | Platelet antagonist | 0.196 0.103 CID_76973589 | CID_76973589 | |
| 0.01 | 0.487 | 0.036 | Purinergic P2Y2 antagonist | 0.036 0.02 CID_154699758 | CID_154699758 | |
| 0.02 | 0.515 | 0.179 | Multidrug resistance-associated protein 1 inhibitor | 0.179 0.015 CID_154699758 | CID_154699758 | |
| 0.02 | 0.56 | 0.149 | Hypolipemic | 0.149 0.137 CID_76973589 | CID_76973589 | |
| 0.016 | 0.586 | 0.347 | Anticoagulant | 0.148 0.082 CID_76973589 0.347 0.022 CID_154699758 | CID_154699758 | |
| 0.014 | 0.604 | 0.048 | Factor IXa inhibitor | 0.047 0.042 CID_76973589 0.048 0.041 CID_154699758 | CID_154699758 | |
| 0.003 | 0.615 | 0.548 | Cholecystokinin agonist | 0.548 0.002 CID_154699758 | CID_154699758 | |
| 0.003 | 0.683 | 0.372 | Cholecystokinin A agonist | 0.372 0.002 CID_154699758 | CID_154699758 | |
| 0.014 | 0.702 | 0.129 | Cell adhesion inhibitor | 0.129 0.059 CID_76973589 | CID_76973589 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |